stockrowPulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) Current ratio
Pulse Biosciences, Inc's current ratio at the end of the quarter to 30 September 2026 was 14.3×, up 3.8× from fiscal 2025 (10.5×). Over the past ten years it has ranged from 2.9× (fiscal 2020) to 19.4× (fiscal 2018); the current reading is higher than 64% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 10.5× | (11.37%) |
| FY2024 | 11.9× | 75.80% |
| FY2023 | 6.8× | (34.97%) |
| FY2022 | 10.4× | 141.66% |
| FY2021 | 4.3× | 45.99% |
| FY2020 | 2.9× | (50.26%) |
| FY2019 | 5.9× | (69.51%) |
| FY2018 | 19.4× | 11.69% |
| FY2017 | 17.4× | 6.02% |
| FY2016 | 16.4× | 170.81% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 14.3× | 49.03% |
| Jun 2026 | 9.6× | 32.60% |
| Mar 2026 | 7.3× | (31.04%) |
| Dec 2025 | 10.5× | 5.12% |
| 40 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| PLSE Pulse Biosciences, Inc | 14.3× |
| MMSI Merit Medical Systems, Inc. compare | 4.5× |
| ATRC AtriCure, Inc. compare | 4.3× |
| TFX Teleflex Incorporated compare | 2.6× |
| NVST Envista Holdings Corporation compare | 2.5× |
| ICUI ICU Medical, Inc. compare | 2.4× |
| WRBY Warby Parker Inc. compare | 2.3× |
| MMED MiniMed Group, Inc. compare | 1.8× |
| STVN Stevanato Group S.p.A. compare | 1.7× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- The full statement